| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Veterinary Biosciences, University of Illinois, Urbana, Illinois 61802
Address all correspondence and requests for reprints to: Dr. Paul Cooke, Department of Veterinary Biosciences, University of Illinois, 2001 South Lincoln Avenue, Urbana, Illinois 61802. E-mail: p-cooke{at}uiuc.edu
Thyroid hormone is a major regulator of Sertoli cell development, and
the present study sought to determine the role of T3 in
Müllerian- inhibiting substance (MIS) messenger RNA (mRNA) expression.
MIS, a Sertoli cell secretory protein that induces Müllerian duct
regression and also may be critical for germ and Leydig cell
development, is maximal perinatally, then decreases as Sertoli cells
mature. The fall in MIS mRNA expression is delayed by hypothyroidism
in vivo, indicating that T3 could regulate
MIS mRNA. However, understanding of the hormonal regulation of MIS has
been limited due partly to the lack of a primary Sertoli cell culture
system in which sustained expression of MIS or its mRNA can be
obtained. We have developed a Sertoli cell culture system for examining
hormonal regulation of MIS mRNA. We then tested the effects of
T3 and/or FSH treatment on MIS mRNA levels in this new
system. Initial studies indicated that MIS mRNA production by 5-day-old
rat Sertoli cells was minimal in vitro. Therefore,
Sertoli cells from 2-day-old rats were cultured for 2 or 4 days. After
2 days in vitro, steady state MIS mRNA levels were
decreased to 36% of the levels seen in freshly isolated Sertoli cells
from 2-day-old rats. However, by day 4 of culture, steady state MIS
mRNA production had recovered to 67% of that seen in freshly isolated
2-day-old Sertoli cells, which closely paralleled the decrease seen in
MIS production in vivo from days 26. MIS mRNA levels
were decreased 53%, 64%, and 86% in cultures treated with 0.01, 0.1,
and 1.0 nM T3 (P < 0.05),
respectively. This decrease in Sertoli cell MIS mRNA did not reflect a
nonspecific effect on cell viability and/or activity, as shown by a
dose-responsive increase in inhibin-
mRNA in these same cultures.
FSH (2.5100 ng/ml) also produced a dose-responsive decrease in MIS
mRNA levels, and FSH and T3 together had an additive
inhibitory effect on MIS mRNA levels, indicating that these hormones
may act through distinct mechanisms. In summary, this is the first
primary culture system in which sustained MIS mRNA production can be
demonstrated, and it should prove useful for understanding the
regulation of MIS in developing Sertoli cells. In addition,
T3 and FSH are major regulators of the postnatal decrease
in MIS production by the rat Sertoli cell, and these hormones may act
through separate pathways.
This article has been cited by other articles:
![]() |
P.-J. Tai, Y.-H. Huang, C.-H. Shih, R.-N. Chen, C.-D. Chen, W.-J. Chen, C.-S. Wang, and K.-H. Lin Direct Regulation of Androgen Receptor-Associated Protein 70 by Thyroid Hormone and Its Receptors Endocrinology, July 1, 2007; 148(7): 3485 - 3495. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Holsberger, S. Jirawatnotai, H. Kiyokawa, and P. S. Cooke Thyroid Hormone Regulates the Cell Cycle Inhibitor p27Kip1 in Postnatal Murine Sertoli Cells Endocrinology, September 1, 2003; 144(9): 3732 - 3738. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Migrenne, C. Racine, F. Guillou, and R. Habert Pituitary Hormones Inhibit the Function and Differentiation of Fetal Sertoli Cells Endocrinology, June 1, 2003; 144(6): 2617 - 2622. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Teixeira, S. Maheswaran, and P. K. Donahoe Mullerian Inhibiting Substance: An Instructive Developmental Hormone with Diagnostic and Possible Therapeutic Applications Endocr. Rev., October 1, 2001; 22(5): 657 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.M.L. Chamindrani Mendis-Handagama and H.B. Siril Ariyaratne Differentiation of the Adult Leydig Cell Population in the Postnatal Testis Biol Reprod, September 1, 2001; 65(3): 660 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Tremblay and R. S. Viger Nuclear Receptor Dax-1 Represses the Transcriptional Cooperation Between GATA-4 and SF-1 in Sertoli Cells Biol Reprod, April 1, 2001; 64(4): 1191 - 1199. [Abstract] [Full Text] |
||||
![]() |
K. Watanabe, T. R. Clarke, A. H. Lane, X. Wang, and P. K. Donahoe Endogenous expression of Mullerian inhibiting substance in early postnatal rat Sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites PNAS, February 15, 2000; 97(4): 1624 - 1629. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |